Global Blood Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLOBAL BLOOD THERAPS, and what generic alternatives to GLOBAL BLOOD THERAPS drugs are available?
GLOBAL BLOOD THERAPS has two approved drugs.
There are eleven US patents protecting GLOBAL BLOOD THERAPS drugs.
There are two hundred and fifty-seven patent family members on GLOBAL BLOOD THERAPS drugs in forty countries and twelve supplementary protection certificates in eleven countries.
Summary for Global Blood Theraps
International Patents: | 257 |
US Patents: | 11 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 2 |
Drugs and US Patents for Global Blood Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | DISCN | Yes | No | 11,944,612 | ⤷ Subscribe | ⤷ Subscribe | ||||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | DISCN | Yes | No | 10,017,491 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET, FOR SUSPENSION;ORAL | 216157-001 | Dec 17, 2021 | DISCN | Yes | No | 10,722,502 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-002 | Oct 14, 2022 | DISCN | Yes | No | 9,018,210 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-002 | Oct 14, 2022 | DISCN | Yes | No | 10,806,733 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-002 | Oct 14, 2022 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Global Blood Theraps Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 3102208 | ⤷ Subscribe |
Eurasian Patent Organization | 201592212 | ⤷ Subscribe |
European Patent Office | 3738434 | ⤷ Subscribe |
Mexico | 358992 | ⤷ Subscribe |
Saudi Arabia | 515361021 | ⤷ Subscribe |
South Korea | 20150132146 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Global Blood Theraps Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2797416 | 32/2022 | Austria | ⤷ Subscribe | PRODUCT NAME: VOXELOTOR ODER EIN TAUTOMER ODER PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1622 (MITTEILUNG) 20220215 |
2797416 | C202230036 | Spain | ⤷ Subscribe | PRODUCT NAME: VOXELOTOR O UN TAUTOMERO O SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/21/1622; DATE OF AUTHORISATION: 20220214; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/21/1622; DATE OF FIRST AUTHORISATION IN EEA: 20220214 |
2797416 | CA 2022 00032 | Denmark | ⤷ Subscribe | PRODUCT NAME: VOXELOTOR ELLER EN TAUTOMER ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1622 20220215 |
2797416 | CR 2022 00032 | Denmark | ⤷ Subscribe | PRODUCT NAME: VOXELOTOR ELLER EN TAUTOMER ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1622 20220215 |
2797416 | PA2022517 | Lithuania | ⤷ Subscribe | PRODUCT NAME: VOKSELOTORAS ARBA TAUTOMERAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA ; REGISTRATION NO/DATE: EU/1/21/1622 20220214 |
2797416 | SPC/GB22/039 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: VOXELOTOR OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/21/1622(FOR NI) 20220215; UK FURTHER MA ON IPSUM 20220215 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.